Brise Pharma

BiotechnologySeries AShanghai, Chinabrisepharma.com

Latest round

Series A

Last raised

Nov 2025

Total raised

$16M

Investors

7

About Brise Pharma

Based in Shanghai, China and founded in 2021, Brise Pharma operates as an innovative biomedical research and development company, focusing on developing innovative biomedical products. The company focuses on oncology and chronic disease field. Based on human genetic and pathological mechanisms to select optimal drug treatments and delivery routes. The Company also builds its pain therapeutic pipeline through a combination of in-house research, co-development and merge, and uses clinical trial strategies to expand the accessibility and commercial value of its drugs. The company generates revenue by providing innovative drugs in the field of pain treatment.

Who invested in Brise Pharma

7 investors across 2 rounds

See all investors in Brise Pharma

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Nov 10, 2025

    Amount

    Undisclosed

    Investors

    Locked

  2. Angel

    Mar 28, 2022

    Amount

    $16M

    Investors

    Locked

Questions about Brise Pharma

Who invested in Brise Pharma?

Brise Pharma has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Brise Pharma raised?

Brise Pharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Brise Pharma last raise money?

Brise Pharma's most recent round on record is a Series A, in Nov 2025.

What does Brise Pharma do?

Based in Shanghai, China and founded in 2021, Brise Pharma operates as an innovative biomedical research and development company, focusing on developing innovative biomedical products.

Where is Brise Pharma headquartered?

Brise Pharma is headquartered in Shanghai, China.

Which VCs invest in companies like Brise Pharma?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Brise Pharma's stage. Their profiles are linked below.

Raising like Brise Pharma? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.